Age and gender disparities in depression and subjective cognitive decline-related outcomes

2020 ◽  
pp. 1-8
Author(s):  
Monique J. Brown ◽  
Nikki L. Hill ◽  
Mohammad Rifat Haider
Geriatrics ◽  
2020 ◽  
Vol 5 (3) ◽  
pp. 51
Author(s):  
Christopher Bolinger ◽  
James Dembowski ◽  
Kimberly Mory

A retrospective study of 1489 hospital records examined the relationship of speech-language pathologist (SLP) consults for dysphagia to age and gender in pneumonia patients from an acute care setting. Age and gender disparities exist in healthcare. The research sought to determine if disparities existed in the presence/absence of SLP dysphagia consults related to age and gender. Results suggested SLPs were consulted on a greater percentage of geriatric patients overall; however, there were differences in the number of consults for each pneumonia type. More males and geriatric patients were seen than females and non-geriatric adults, respectively. Results may be used to address local hospital policies and protocols and thus increase quality of care by improving morbidity and mortality outcomes of geriatric patients with pneumonia.


2012 ◽  
Vol 12 (1) ◽  
Author(s):  
Malgorzata Miszkurka ◽  
Slim Haddad ◽  
Étienne V Langlois ◽  
Ellen E Freeman ◽  
Seni Kouanda ◽  
...  

2021 ◽  
Author(s):  
Wyllians Borelli ◽  
Carolina Formoso ◽  
Andrei Bieger ◽  
Eduardo Zimmer ◽  
Marcia Chaves ◽  
...  

Background: Subjective Cognitive Decline may represent the earliest clinical manifestation of the Alzheimer’s continuum. A continental-size country like Brazil demands regionalized strategies to provide adequate public health strategies. Objectives: To analyze the prevalence of SCD in Brazilian regions, sex and genders. Methods: Data was gathered from a complex-sample epidemiological study named ELSI (Estudo Longitudinal da Saúde de Idosos). SCD criteria was applied within the dataset. Weighting for complex-sampling was performed. Data was analyzed according to national region, sex and gender. Results: Overall nationwide prevalence of SCD was 15.48%. Prevalence of SCD was the highest in Midwest (19.9%), followed by Northeast (17%), North (16.9%), South (14.6%) and Southeast (14.2%, p <0.0001). Among adults, males in the North showed the highest prevalence of SCD (27.5%), while the lowest prevalence was in females in the Southeast (14.4%). Among older adults, the highest prevalence was in females in the North (19.2%), while females in the Southeast showed the lowest (11.2%). Prevalence of SCD was statistically similar in females and males (15.6% vs. 16.1%, p=0.6). Conclusions: Brazil exhibits distinct profiles of SCD according to regions, sex and genders that should be analyzed by policymakers in public health. The Midwest presented the highest prevalence of SCD. Individually, male adults and female older adults in the North presented the highest prevalence in Brazil.


2013 ◽  
Vol 34 (10) ◽  
pp. 1711-1717 ◽  
Author(s):  
Sotirios Giannopoulos ◽  
Aristeidis H. Katsanos ◽  
Spyros N. Vasdekis ◽  
Efstathios Boviatsis ◽  
Konstantinos Ι. Voumvourakis ◽  
...  

2020 ◽  
Author(s):  
Jacqueline Mogle ◽  
Nikki Hill ◽  
Jennifer Turner

UNSTRUCTURED Increasing evidence promotes the clinical utility of self-reported memory problems for detecting early impairment associated with Alzheimer’s disease (AD). However, past work investigating memory problems often conflated the types of problems (i.e., retrospective and prospective) with their features (i.e., frequency and consequences). This bias limits the specificity of traditional measures of memory problems and minimizes their ability to detect differential trajectories associated with cognitive decline. In the present study, we use a novel measure of self-reported memory problems that uses daily reports of memory lapses to disentangle types from features to analyze the impact of each dimension in two longitudinal datasets. Further, this study explores the individual difference factors of age and gender as potential moderators of the relationships between self-reported memory lapses and objective cognitive decline. This study uses multilevel, coordinated analyses across two measurement burst datasets to examine the links between features and consequences of memory lapses (retrospective and prospective) and their association with objective cognitive decline. The current sample (n = 535; ages 50-85 years; 61% women) is drawn from two ongoing, nationally funded research studies: the Effects of Stress on Cognitive Aging, Physiology, and Emotion Study and the Einstein Aging Study. Both studies assess the daily experience of memory lapses, including the type as well as the emotional and functional outcomes, and objective measures of cognition such as processing speed and episodic memory. We will use multilevel modeling to test our conceptual model that differences in frequency and types of memory lapses show differential trends in their relationships with cognitive decline and that these relationships vary by age and gender of participant. The early and accurate identification of individuals most at risk for cognitive decline is of paramount importance. Previous research exploring self-reported memory problems and AD is promising, however limitations in measurement may explain prior reports of inconsistences. The current study addresses these concerns by examining daily reports of memory lapses, how these vary by age and gender, and their relationship with objective cognitive performance. Overall this study aims to identify key features of daily memory lapses and the differential trajectories that best predict cognitive decline to help inform future AD risk screening tools.


2021 ◽  
Vol 8 ◽  
Author(s):  
Xiaomo Xiong ◽  
Jing Yuan ◽  
Minghui Li ◽  
Bin Jiang ◽  
Z. Kevin Lu

Background: Two coronavirus disease 2019 (COVID-19) vaccines have received emergency use authorizations in the U.S. However, the safety of these vaccines in the real-world remains unknown.Methods: We reviewed adverse events (AEs) following COVID-19 vaccination among adults in the Vaccine Adverse Event Reporting System (VAERS) from December 14, 2020, through January 22, 2021. We compared the top 10 AEs, serious AEs, along with office and emergency room (ER) visits by age (18–64 years, ≥65 years) and gender (female, male).Results: There were age and gender disparities among adults with AEs following COVID-19 vaccination. Compared to younger adults aged between 18 and 64 years, older adults were more likely to report serious AEs, death, permanent disability, and hospitalization. Males were more likely to report serious AEs, death, and hospitalization compared to females.Conclusions: COVID-19 vaccines are generally safe but possible age and gender disparities in reported AEs may exist.


2021 ◽  
Vol 42 (Supplement_1) ◽  
Author(s):  
Y U Grinshtein ◽  
R Ruf ◽  
V Shabalin

Abstract Introduction Lipitension is the presence of hypertension and dyslipidaemia in one person. It multiplies cardiovascular risk up to three-fold and therefore requires timely diagnosing and treatment. Purpose In the present study, we calculated the prevalence of lipitension and its disparities depending on gender and age. Methods We used the randomized sample of the ESSE-RF study that included 1603 urban and rural Krasnoyarsk Krai inhabitants aged 25–64. Each study participant signed informed consent and underwent the questionnaire, office blood pressure measurement, anthropometry, and biochemical blood analysis. Hypertension criteria were the measured systolic blood pressure at 140 mm Hg or higher, the measured diastolic blood pressure at 90 mm Hg or higher, or antihypertensive medications intake. Dyslipidaemia criteria were the total cholesterol level higher than 5.0 mmol/l, the low-density lipoprotein level higher than 3.0 mmol/l, the high-density lipoprotein level lower than 1.0 mmol/l in males and 1.2 mmol/l in females, or triglycerides level higher than 1.7 mmol/l. Results In 40.0% of people, we found a combination of at least one hypertension criterion and at least one dyslipidaemia criterion. The prevalence of lipitension significantly (chi-square for trend; p&lt;0.001) increased from 10.7% in the 25–34 age group to 66.6% in the 55–64 age group. At a younger age, males had dyslipidaemia more frequently than females, while at 55–64, the prevalence of lipitension was higher in females. The details of age and gender disparities are shown in Table 1. Conclusion At least 40% of the general population and two-thirds of people older than 55 have lipitension and need a combined antihypertensive and lipid-lowering therapy. FUNDunding Acknowledgement Type of funding sources: None. Table 1


Sign in / Sign up

Export Citation Format

Share Document